Immunotherapy & Oncology
Cancer treatment has moved from poisoning dividing cells towards directing the immune system at the tumour, and towards drugs that carry their payload only to cancerous tissue. It absorbs more drug development spending than any other area.
388 stocks
| # | Name | Holding | Trade Value |
Theme Stocks |
% of Portfolio | Status | |
|---|---|---|---|---|---|---|---|
| 1 |
BlackRock
New York
| $210B | +$2.43B | 203 | 3.12% | Increased |
|
| 2 |
Vanguard Capital Management
Malvern,
Pennsylvania
| $155B | +$636M | 197 | 3.31% | Increased |
|
| 3 |
State Street
Boston,
Massachusetts
| $116B | +$1.62B | 175 | 3.44% | Increased |
|
| 4 |
Vanguard Portfolio Management
Malvern,
Pennsylvania
| $65.1B | +$1.48B | 114 | 2.93% | Increased |
|
| 5 |
Geode Capital Management
Boston,
Massachusetts
| $58.8B | +$632M | 212 | 3.14% | Increased |
|
| 6 |
JP Morgan Chase
New York
| $54B | -$8.47B | 180 | 2.99% | Reduced |
|
| 7 |
Fidelity Investments
Boston,
Massachusetts
| $53.8B | -$52.3M | 152 | 2.33% | Reduced |
|
| 8 |
Morgan Stanley
New York
| $47.9B | -$615M | 223 | 2.53% | Reduced |
|
| 9 |
Evelyn Partners
London,
| $41.6B | +$496M | 13 | 88.78% | New |
|
| 10 |
Norges Bank
Oslo,
Norway
| $36.9B | +$34.7B | 27 | 3.67% | New |
|
| 11 |
Capital World Investors
Los Angeles,
California
| $33.7B | +$1.91B | 16 | 3.99% | Increased |
|
| 12 |
Wellington Management Group
Boston,
Massachusetts
| $33B | +$261M | 83 | 5.68% | Increased |
|
| 13 |
T. Rowe Price Associates
Baltimore,
Maryland
| $30.9B | +$2.39B | 117 | 3.1% | Increased |
|
| 14 |
Bank of America
Charlotte,
North Carolina
| $30.5B | -$1.3B | 142 | 1.97% | Reduced |
|
| 15 |
Charles Schwab
San Francisco,
California
| $29.7B | +$1.73B | 119 | 3.95% | Increased |
|
| 16 |
Invesco
Atlanta,
Georgia
| $27.7B | -$565M | 121 | 2.19% | Reduced |
|
| 17 |
Northern Trust
Chicago,
Illinois
| $26.6B | -$395M | 178 | 3.09% | Reduced |
|
| 18 |
Goldman Sachs
New York
| $25.4B | +$885M | 144 | 2.21% | Increased |
|
| 19 |
Legal & General Group
London,
United Kingdom
| $21B | -$206M | 115 | 4.39% | Reduced |
|
| 20 |
Fisher Asset Management
Camas,
Washington
| $20.7B | +$2.91B | 33 | 6.16% | Increased |
|
| 21 |
Bank of New York Mellon
New York
| $20.4B | -$229M | 126 | 3.35% | Reduced |
|
| 22 |
Franklin Resources
San Mateo,
California
| $20.2B | +$830M | 76 | 4.38% | Increased |
|
| 23 |
UBS AM
Chicago,
Illinois
| $18.4B | -$201M | 94 | 3.35% | Reduced |
|
| 24 |
Dimensional Fund Advisors
Austin,
Texas
| $17.1B | +$871M | 103 | 3.1% | Increased |
|
| 25 |
Capital Research Global Investors
Los Angeles,
California
| $15.9B | -$1.81B | 9 | 2.22% | Reduced |
|